MSMichael J. Sayegh

Michael J. Sayegh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael J. Sayegh has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preoperative Risk Factors for Opioid Use Predict Self‐Reported Health and Function Up to 6 Months After Anterior Cruciate Ligament Reconstruction

    by Eric V. Neufeld, William DeGouveia, Camille Pinpin, Matthew Zinner, Michael J. Sayegh, Michael J. Meade, Steven E. Rokito

    Purpose: To identify risk factors that predict the need for rescue opioid use and patient‐reported outcomes following an opioid‐limiting postoperative analgesia protocol after anterior cruciate ligament reconstruction. Methods: This prospective cohort study recruited 44 patients undergoing primary arthroscopic‐assisted anterior cruciate ligament reconstruction. Preoperatively, patients completed questionnaires including demographics, medical history, Visual Analog Scale (VAS), Brief Resilience Scale, Six‐Item State‐Trait Anxiety Inventory, Patient Health Questionnaire‐2, Single Assessment Numeric Evaluation score, and patient‐reported outcome measures (PROMs) including Patient‐Reported Outcomes Measurement Information System physical component. Postoperatively, patients received acetaminophen, meloxicam, tramadol, gabapentin, and oxycodone. Morphine milligram equivalents (MMEs) and VAS were assessed at multiple timepoints through 6 months. PROMs were completed at 3 and 6 months. Patients were analyzed as a single group and partitioned by Brief Resilience Scale and Six‐Item State‐Trait Anxiety Inventory scores into low‐normal (1.00‐4.30) and high (4.31‐5.00) resilience, and low (20‐37) and moderate‐high (38‐80) anxiety groups, respectively. Results: Prior opioid use positively predicted VAS and MME at 48 to 72 hours and MME at 6 weeks. Body mass index positively predicted MME at 2 weeks. Surgical history negatively predicted VAS at 48 to 72 hours, but positively predicted change in Single Assessment Numeric Evaluation score at 3 and 6 months and Patient‐Reported Outcomes Measurement Information System physical component score at 6 months. Conclusions: Only 4.8% of patients required opioid medications more than 2 weeks postoperatively. Patients with prior opioid use exhibited greater postoperative pain and narcotic consumption. Higher body mass index linked to increased opioid use at 2 weeks, whereas individuals with prior surgical history reported less pain and improved PROMs postoperatively. Measurements of patient resilience and anxiety show little effect on postoperative pain, opioid consumption, and PROMs requiring further study. Level of Evidence: Level III, retrospective prognostic case series.

  • Open Access

    Preoperative Risk Factors for Opioid Use Predict Self-Reported Health and Function Up to 6 Months Following Anterior Cruciate Ligament Reconstruction

    by Eric V. Neufeld, William M. DeGouveia, Camille Pinpin, Matthew Zinner, Michael J. Sayegh, Michael J. Meade, Steven E. Rokito

  • Rare Variant of the Radial Artery Causing Compression of the Superficial Radial Nerve

    by Michael J. Sayegh, Joshua M. Keefer, Zhongyu Li

    O it. The nerve was mobilized from the artery with fascial releases. The patient had symptom resolution postoperatively. Conclusion: To our knowledge, this cause of compression has not been described before and should be considered in a differential diagnosis. In addition, clinicians should be aware of this anatomical variant during venipunctures and surgical approaches....


  • Does Time Spent in the Post-Anesthesia Care Unit Affect Hospital Lengths of Stay following Primary Total Knee Arthroplasty?

    by Michael J. Sayegh, Luke J. Garbarino, Peter A. Gold, Hiba K. Anis, Zhongming Chen, Nipun Sodhi, Jonathan R. Danoff, Michael A. Mont

    Given the current healthcare economic environment, substantial efforts have been made to help streamline the in-hospital care for total knee arthroplasty (TKA) patients. While potential cost-reducing factors have been identified in the literature, analyses specifically considering post-anesthesia care unit (PACU) lengths of stay (LOS) are lacking. Therefore, the purpose of this study was to identify factors associated with (1) longer PACU LOS as well as (2) longer Hospital LOS. Prospectively collected TKA data from seven participating hospitals within a large health system were evaluated for patient demographics, body mass indices, Charlson Comorbidity Indices (CCI), surgeon volumes/training, admission types, anesthesia types, PACU LOS, and overall hospital LOS. Complete data was available for 1,690 patients (1,082 females, mean age: 67 years). Univariate and multivariate analytical models were constructed to identify which factors were predictive of longer PACU and overall hospital LOS. Same-day admissions, higher volume surgeons (≥ 100 cases per year), fellowship-trained arthroplasty surgeons, and longer operative times were associated with longer PACU LOS (p < 0.05). Multivariate analyses found age more than or equal to 65 years (β= 0.124) and CCI more than or equal to 3 (β= 0.088) to be associated with longer hospital LOS (p < 0.001). Operative times, PACU LOS, and procedure times (operative time plus PACU LOS) were not associated with longer hospital LOS (p > 0.05). These data identify associative factors for PACU LOS, as well as the influence of time spent in the PACU on overall hospital LOS. Interestingly, this analysis revealed that patients of arthroplasty fellowship-trained and higher-volume surgeons had longer PACU LOS; however, this could be explained by the observation that these particular surgeons tend to perform more complex deformity cases. Also of importance, increased PACU LOS, meaning the patient spent more time in a high-monitored setting immediately after surgery, did not necessarily confer a longer overall hospital LOS. Based on these data, it may be more beneficial to identify alternate sources than time spent in the operating room or PACU to potentially help reduce overall hospital LOS. Level of Evidence II, prospective cohort


  • Effects of Premixing Betamethasone and Lidocaine on Chondrocyte Inflammation in an In Vitro Model

    by Michael J. Sayegh, Camille Pinpin, Christopher G. Larsen, Eric V. Neufeld, Jessica M. Intravia, Kate W. Nellans, Lewis B. Lane, Daniel Grande

    Background: It is common practice for hand surgeons to premix corticosteroids with a local anesthetic and store the mixture in pre-loaded syringes for rapid use during clinic. However, any possible loss of efficacy with this practice has never been studied. The purpose of this study, therefore, is to determine whether premixing betamethasone sodium phosphate/betamethasone acetate (BSP) and lidocaine (L) at different time intervals from injection has diminishing anti-inflammatory effects on chondrocytes in vitro. Methods: Human articular chondrocytes were partitioned into six groups: two controls and four experimental conditions. The negative control had growth media only. The positive control had growth media and inflammatory cytokines (interleukin-1β and oncostatin M). Experimental conditions were additionally treated with BSP alone or BSP mixed with lidocaine (BSP + L) at the time of treatment (0 hours), or at 4 or 24 hours prior. Relative expressions of inflammatory genes were measured. Results: Relative to the positive control, chondrocytes in all experimental conditions decreased expression of TNF-α, MMP-3, and ADAMTS-4. Chondrocytes exposed to BSP only or BSP + L at 4 hours or 24 hours prior to treatment decreased expression of IL-8. Chondrocytes exposed to BSP only or BSP + L at 0 hours or 4 hours prior to treatment decreased expression of MMP-1. There were no significant differences in expression of IL-6 or MMP-13. Conclusions: Treatment with BSP + L prepared in pre-loaded syringes at varying time intervals up to 24 hours prior to injection does not significantly impact the ability of the mixture to reduce expression of certain key inflammatory mediators in vitro.


  • Ulnar Neuropathy After Intermittent Prone Positioning for COVID-19 Infection

    by Michael J. Sayegh, Christopher G. Larsen, Camille Pinpin, Jessica M. Intravia, Kate W. Nellans

    Case: We describe a preliminary report of 3 cases of ulnar neuropathy after coronavirus disease 2019 (COVID-19) infection and treatment with intermittent prone positioning. Conclusion: Ulnar neuropathy may be associated with recent COVID-19 infection. The natural process of the disease and intermittent prone positioning are likely risk factors contributing to this finding. Conservative management seems to lead to improvement of symptoms.


  • Changing trends in the management of proximal humerus fractures in New York State

    by Michael J. Sayegh, Ryan A. Nixon, Dean C. Perfetti, Steven E. Rokito, Nicholas A. Sgaglione